LIFEVANTAGE CORP Deferred Tax Assets, Operating Loss Carryforwards
LIFEVANTAGE CORP (LFVN) had Deferred Tax Assets, Operating Loss Carryforwards of $218.00 thousand as of 2026-06-30, per its 10-K filed 2026-08-27.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-08-27
- 2026-06-30: Deferred Tax Assets, Operating Loss Carryforwards $218.00K.
- 2025-06-30: Deferred Tax Assets, Operating Loss Carryforwards $234.00K.
- 2024-06-30: Deferred Tax Assets, Operating Loss Carryforwards $271.00K.
- 2023-06-30: Deferred Tax Assets, Operating Loss Carryforwards $250.00K.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards | Deferred Tax Assets, Operating Loss Carryforwards as first filed |
|---|---|---|
| 2026-06-30 | $218.00K 10-K · filed 2026-08-27 | |
| 2025-06-30 | $234.00K 10-K · filed 2026-08-27 | |
| 2024-06-30 | $271.00K 10-K · filed 2025-09-04 | |
| 2023-06-30 | $250.00K 10-K · filed 2024-08-28 | |
| 2022-06-30 | $292.00K 10-K · filed 2023-08-28 | |
| 2021-06-30 | $271.00K 10-K · filed 2022-08-23 | |
| 2020-06-30 | $501.00K 10-K · filed 2021-08-19 | |
| 2019-06-30 | $448.00K 10-K · filed 2020-08-18 | |
| 2018-06-30 | $574.00K 10-K · filed 2019-08-14 | |
| 2017-06-30 | $536.00K 10-K · filed 2018-08-15 | |
| 2016-06-30 | $519.00K 10-K · filed 2017-09-07 | $651.00K 10-K · filed 2016-12-12 |
| 2015-06-30 | $656.00K 10-K · filed 2016-12-12 | |
| 2014-06-30 | $1.02M 10-K · filed 2015-09-01 | |
| 2013-06-30 | $1.77M 10-K · filed 2014-09-10 | |
| 2012-06-30 | $2.45M 10-K · filed 2013-09-12 | |
| 2011-06-30 | $4.83M 10-K · filed 2012-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |